4 July 2024
Inspiration Healthcare Group
plc
("Inspiration Healthcare", the "Company" or the
"Group")
Grant of
Options
Inspiration Healthcare Group plc
(AIM: IHC), the global medical technology company, announces that
it has granted a total of 672,415 nil cost options over
ordinary shares of 10 pence each in the capital of the Company
("Options") under the Inspiration Healthcare Group Long Term
Incentive Plan (the "LTIP"), to Alan Olby (Chief Financial Officer)
and Brook Nolson (Chief Operating Officer), both of whom are
Persons Discharging Managerial Responsibilities ("PDMRs") as
detailed below.
The Options are exercisable at nil
cost and are subject to Remuneration Committee discretion over a
two-year period ending on 2 July 2026.
For further
information:
|
Inspiration Healthcare Group plc
|
Tel: +44 (0)330 175 0000
|
|
Roy Davis, Executive Chair and
Interim CEO
|
|
|
Alan Olby, Chief Financial
Officer
|
|
|
|
|
|
Liberum (Nominated Adviser & Broker)
|
Tel: +44 (0)20 3100 2000
|
|
Richard Lindley, Will King, Joshua
Borlant
|
|
|
|
|
|
Walbrook PR Ltd (Media and Investor
Relations)
|
Tel: +44 (0)20 7933 8700
|
|
Anna Dunphy/Stephanie Cuthbert/Louis
Ashe-Jepson
|
|
|
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
1. Alan Olby
2. Brook Nolson
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
1. PDMR (CFO)
2. PDMR (COO)
|
|
b)
|
Initial notification
/Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Inspiration Healthcare Group
plc
|
|
b)
|
LEI
|
213800GKFT3ENAPMDL15
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Options
over Ordinary Shares of 10p each in
the capital of the Company
ISIN: GB00BXDZL105
|
|
b)
|
Nature of the transaction
|
Grant of Options under the Long Term Incentive
Plan
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
1. Nil
2. Nil
|
1. 356,537
2. 315,878
|
|
|
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A - single transaction
|
|
e)
|
Date of the transaction
|
3 July 2024
|
|
f)
|
Place of the transaction
|
Outside of a trading
venue
|
About Inspiration Healthcare Group plc
Inspiration Healthcare (AIM: IHC)
designs, manufactures and markets pioneering medical technology.
Based in the UK, the Company specialises in neonatal intensive care
medical devices, which are addressing a critical need to help to
save the lives and improve the outcomes of patients, starting with
the very first breaths of life.
The Company has a broad portfolio of
its own products and complementary distributed products, for use in
neonatal intensive care designed to support even the most premature
babies throughout their hospital stay. Its own branded products
range from highly sophisticated capital equipment such as
ventilators for life support through to single-use
disposables.
The Company sells its products
directly to hospitals and healthcare providers in the UK and
Ireland, where it also distributes a range of advanced medical
technologies for infusion therapy. In the rest of the world
the Company has an established network of distribution partners
around the world giving access to more than 75
countries.
The Company operates in the UK from
its world-class Manufacturing and Technology Centre in Croydon,
South London and in the USA from its facility in Melbourne,
Florida.
Further information on Inspiration
Healthcare can be found at www.inspirationhealthcaregroup.com.